Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin for prevention of venous thrombosis after varicose vein surgery
IRCT20260208068800N1Phase 3Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of enoxaparin in Varicose veins of lower extremities (VVLE), sponsored by Shahrekord University of Medical Sciences. Started Apr 2026; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
Varicose veins of lower extremities (VVLE)
Beyond the preview
Go deeper on IRCT20260208068800N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260208068800N1.